← All stocks

Edesa Biotech, Inc.

EDSA Net buying
CIK 0001540159 #4753 in the set updated 21 Sep 2026
Bought (12 mo)
$233.05K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$233.05K
+$233.05K against sales at will

By person

9 insiders · 9 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Nijhawan Pardeep
Chief Executive Officer
$229.91K (8)
+$229.91K
1,822,230
$12.02M
+83.8%
Brooks Michael J
President
$3.14K (1)
+$3.14K
291,479
$1.92M
+1,550%
Weiler Peter J.
Chief Financial Officer
129,609
$855.28K
Marshall Patrick
Director
71,666
$472.92K
Sistilli Carlo
Director
49,417
$326.10K
MacDonald Sean Arthur
Director
41,054
$270.91K
+1,900%
Chypyha Joan
Director
30,029
$198.16K
+103,448%
Olson Charles V
Director
30,000
$197.97K
Liu Da David
Director
24,501
$161.68K

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 3,467,658 to 9,641,031 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 649,011
History held since 21 Dec 2016